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Abstract
Background: The cytochromes P450 are a superfamily of enzymes that control 
the	 synthesis	 of	 the	 biologically	 active	 form	 of	 vitamin	 D,	 1,25-dihydroxyvita-
min	D3.	These	enzymes	contribute	to	the	formation	of	1,25-dihydroxyvitamin	D3,	
which	 starts	with	 a	 25-hydroxylation	 by	CYP2R1 and CYP27A1 and a subsequent 
1α-hydroxylation	via	CYP27B1.
Methods: By	using	quantitative	real-time	polymerase	chain	reaction	(qRT-PCR),	we	
analyzed	the	expression	ratio	of	CYP2R1,	CYP27A1 and CYP27B1 genes within the 
vitamin	D	metabolic	pathway	 in	a	total	of	75	colorectal	cancer	 (CRC)	tissues	com-
pared	to	the	adjacent	tissues.	Furthermore,	we	evaluated	the	association	of	CYP27B1 
rs4646536 and CYP2R1	rs12794714	and	rs10766196	polymorphisms	with	CRC	risk	
in	a	total	of	490	subjects,	including	245	CRC	patients	and	245	non-cancer	controls.	
The	genotyping	was	performed	using	tetra-primer	amplification	refractory	mutation	
system	polymerase	chain	reaction	(TP-ARMS–PCR)	method.
Results: The results indicated 2.3 and 2.7 upregulation of CYP2R1 and CYP27B1 
genes	 in	 colorectal	 cancer	 tissues	 compared	 to	 the	 adjacent	 tissues,	 respectively.	
Rs12794714	AG	genotype	 increased	the	risk	of	CRC	(P =	 .03).	Furthermore,	a	sig-
nificant	association	was	observed	under	the	dominant	inheritance	model	(P =	.039).
Conclusion: CYP2R1 and CYP27B1	genes	were	over-expressed	in	CRC	samples	com-
pared	to	the	adjacent	control	tissues.	Furthermore,	CYP2R1	rs12794714	variant	was	
associated with the risk of CRC in the studied samples. CYP2R1	 rs10766196	 and	
CYP27B1 rs4646536 are not responsible for CYP2R1 and CYP27B1	genes	expression	
alteration,	respectively,	but	CYP2R1	rs12794714	polymorphism	may	be	the	reason	of	
CYP2R1 upregulation and increased the risk of CRC.
K E Y W O R D S
colorectal	cancer,	CYP27B1,	CYP2R1,	single-nucleotide	polymorphism,	vitamin	D
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1  | INTRODUC TION
According	to	the	global	cancer	project	estimation,	colorectal	cancer	
(CRC)	is	the	second	leading	cause	of	cancer-related	death	worldwide,	
accounting for around 1.8 million new cases and 860 000 deaths in 
2018.1	 The	 Iranian	National	Cancer	Registry	 (IACR)	Report	 shows	
that the incidence of CRC has increased during the last 25 years.2 
Genetic	 factors,	 epigenetic	 alterations,	 and	 environmental	 factors	
may be associated with CRC progression.3,4	Vitamin	D	 is	a	steroid	
hormone and is involved in cell proliferation and differentiation.5 
Multiple lines of evidence have shown the vitamin D pathway dys-
regulation	 in	 different	 types	 of	 cancer,	 for	 instance,	 cytochrome	
P450	 (CYP)	 genes	 such	 as	CYP2R1,	CYP27A1,	 and	CYP27B1.6-8 In 
summary,	vitamin	D	synthesis	 is	 as	 follows:	CYP2R1 and CYP27A1 
convert	vitamin	D	to	circulating	25(OH)D.	Then,	CYP27B1 converts 
25(OH)D	to	1,	25-dihydroxyvitamin	D,	which	is	the	biologically	ac-
tive form of the vitamin D.9 Increased concentrations of CYP27A1 
had	been	 reported	 in	 the	nuclei	 of	 normal	 colonic	 epithelia,	 aber-
rant	 crypt	 foci	 (ACF),	 and	 adenomatous	 polyps.7 The primary site 
of CYP27B1	expression	is	 in	the	proximal	tubule	of	the	kidney,	but	
it	 is	also	expressed	 in	other	tissues	such	as	the	colon.10,11 CYP2R1 
is	expressed	 in	colon;	however,	 liver	 is	 the	primary	site	of	CYP2R1 
expression.12,13	 On	 the	 other	 hand,	 single-nucleotide	 polymor-
phisms	(SNPs)	could	modify	the	gene	expression	and,	consequently,	
influence the risk of cancer.14	Additionally,	 numerous	 studies	 sug-
gested	that	SNPs	in	the	CYP2R1 and CYP27B1 were found to be as-
sociated with CRC risk.15,16 Gong et al have shown the association 
between intronic CYP27B1	 rs4646536,	 located	at	 the	 long	arm	of	
chromosome	12,	and	CRC	risk.	However,	Dong	et	al	did	not	find	any	
significant association between this polymorphism and colon can-
cer.15,17 Nam et al18 hypothesized that the CYP2R1	rs12794714	and	
rs10766196	variants,	both	located	at	the	CpG	island,	may	modulate	
the gene transcription and were associated with the risk of develop-
ing	 type	1	diabetes.	 Furthermore,	CYP2R1	 rs12794714	was	 found	
to	significantly	associate	with	CRC	and	serum	level	of	25(OH)D3.16 
While several studies have investigated CYP27B1 and CYP2R1	 ex-
pression	 and	 genetic	 association	 separately	 in	CRC,	 only	 a	 few	of	
them	have	simultaneously	 investigated	the	expression	and	genetic	
association of CYP27B1 and CYP2R1	with	CRC.	Hence,	the	current	
study aimed to investigate the relation between CYP2R1,	CYP27B1, 
and CYP27A1	expressions	and	CRC.	We	also	intended	to	assess	the	
contribution of CYP2R1 and CYP27B1 polymorphisms in the patho-
genesis of CRC in a sample of Iranian population.
2  | MATERIAL S AND METHODS
2.1 | Study population
Colorectal	cancer	patients	were	identified	in	endoscopy,	oncology,	
or	surgery	clinics	from	July	2012	to	December	2015.	For	DNA	ex-
traction,	blood	samples	were	obtained	from	245	patients	with	spo-
radic	colorectal	cancer	and	245	age-	and	sex-matched	cancer-free	
controls	and	collected	in	ethylene-diamine	tetra	acetic	acid	(EDTA)	
tubes.	Patients	with	a	history	of	hereditary	or	malignant	diseases,	
and	diseases	affecting	the	digestive	system	were	excluded	from	the	
study.	 For	 expression	 analysis,	 a	 total	 of	 75	 CRC	 fresh	 colorectal	
cancer tissues and adjacent control tissues were obtained from the 
Institute	for	Gastroenterology	and	Liver	Diseases	(Shahid	Beheshti	
University	 of	 Medical	 Sciences).	 All	 specimens	 were	 immediately	
stored	at	−80°C	until	RNA	extraction.	Patients	who	had	undergone	
radiotherapy	or	chemotherapy	were	excluded	from	expression	anal-
ysis.	This	case-control	study	was	approved	by	the	Gastroenterology	
and	 Liver	 Diseases	 Research	 Center	 Ethics	 Committee	 (Code:	
IR.SBMU.RCGLD.REC.1397.006).	 Written	 informed	 consent	 was	
obtained from all participants before entering the study.
2.2 | RNA isolation and reverse transcription
Total	 RNA	 was	 extracted	 from	 fresh-frozen	 CRC	 tissues	 and	 the	
noncancerous	tissues	using	a	GeneAll	Hybrid-R™	RNA	purification	
kit	(Geneall	Biotechnology	Co.	Ltd)	according	to	the	manufacturer's	
protocol.	The	quantity	and	 the	quality	of	 the	 total	extracted	RNA	
were estimated using NanoDrop®	 ND-1000	 spectrophotometer	
(Thermo	Fisher	Scientific).	The	RNA	purity	was	evaluated	according	
TA B L E  1  List	of	primer	pairs	for	qRT-PCR
Genes Forward primer Reverse primer Amplicon size (bp)
CYP2R1 CCGGGGCTGCCATTTATCG AAACTGAAGATCTCTCCGTACACC 107
CYP27B1 GTCCAGACAGCACTCCACTC ACCACAGGGTACAGTCTTAGC 137
CYP27A1 CACGACATCCAACACGCTGAC CCACAGGGTAGAGACGCAGAG 185
Beta-2-microglogulin TGTCTTTCAGCAAGGACTGGT TGCTTACATGTCTCGATCCCAC 143
Abbreviation:	bp,	base	pair.
Funding information
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to	 the	 A260/A280	 ratio.	 The	 integrity	 of	 RNA	 was	 assessed	 by	
electrophoresis on a denaturing 1% agarose gel. Complementary 
DNA	(cDNA)	was	reversely	transcribed	from	0.5	to	1	μg of DNase 
I-treated	RNA	using	a	Revert	Aid	First-Strand	cDNA	Synthesis	Kit	
according	to	manufacturer	instruction	(Thermo	Fisher	Scientific).
2.3 | Quantitative real-time PCR
The	quantitative	real-time	PCR	(qRT-PCR)	reaction	was	performed	in	
96-well	plates	using	2.0X	RealQ-PCR	Master	Mix®	with	SYBR	Green	
(Ampliqon)	on	ABI	StepOnePlus™	Real-Time	PCR	Detection	System	
(Applied	Biosystems).	All	qRT-PCR	primers	were	designed	by	Allele	
ID	6	software	(Premier	Biosoft)	and	described	in	Table	1.	Each	reac-
tion	mixture	consisted	of	1	µL	cDNA	(10	ng),	10	µL	2X	RealQ-PCR	
Master	Mix®,	1	µL	(10	pmol/µL)	of	both	forward	and	reverse	primers,	
and 7 µL	of	PCR-grade	water,	equating	to	a	final	volume	of	20	µL.	
The	beta-2	microglobulin	 (β2M)	mRNA	was	used	 as	 the	 reference	
gene. β2M was selected as the reference gene according to previous 
research for identification of housekeeping control genes in colorec-
tal cancer.19 The thermal profile of the reaction was performed using 
the	following	conditions:	initial	denaturation	at	95°C	for	15	minutes;	
followed	by	40	cycles	at	95°C	for	15	seconds	and	60°C	for	60	sec-
onds followed by melting curve stage assessment. The melting curve 
profile and agarose gel electrophoresis were performed to verify the 
specificity of primers and the authenticity of the PCR products.
2.4 | DNA extraction and genotyping
Genomic	DNA	was	extracted	from	peripheral	blood	leukocytes	using	
the	 standard	 salting-out	 procedure	 and	 stored	 at	 −20°C	 until	 fur-
ther use.20	The	primers	used	to	amplify	the	target	DNA	sequences,	
which were designed by using Primer1 online software available 
from	 http://prime	r1.soton.ac.uk/prime	r1.html,	 are	 presented	 in	
Table	2.	Three	single-nucleotide	polymorphisms,	including	CYP27B1 
rs4646536 and CYP2R1	 rs12794714	and	 rs10766196,	were	ampli-
fied	using	polymerase	chain	reaction	(PCR)	contained	2	µL	template	
DNA	(100-200	ng	DNA),	12.5	µL	Taq	DNA	Polymerase	2X	Master	
Mix	 (Amplicon),	1	µL	of	each	primer	 (10	pmol),	and	6.5	µL	DNase-
free water in a total volume of 25 µL.	PCR	cycling	was	performed	
on	 a	 GeneTouch	 thermocycler	 (BIOER).	 Amplification	 cycling	 re-
actions were carried out under the following conditions: an initial 
denaturation	at	95°C	for	5	minutes,	followed	by	32	cycles	at	95°C	
for	30	seconds,	annealing	for	50	seconds	at	different	temperatures	
(Table	2),	and	extension	at	72°C	for	1	minute,	then	a	final	incubation	
step	at	72°C	for	7	minutes.	Finally,	the	products	were	separated	via	
electrophoresis	on	2%	agarose	gel	containing	RedSafe	stain	in	0.5× 
tris/borate/EDTA	(TBE).	To	confirm	the	accuracy	of	genotyping,	the	
randomly	selected	samples	(10%)	were	re-genotyped.	SNPs	had	the	
following	 characteristics:	 (a)	 had	 a	 minor	 allele	 frequency	 greater	
than	10%	and	 (b)	were	potentially	 functional	predicted	by	 in	silico	
analysis.
2.5 | Statistical analysis
Analysis	 of	 inheritance	 models	 and	 deviations	 from	 Hardy-
Weinberg	 equilibrium	 were	 performed	 using	 the	 online	 SNPStats	
program	 available	 from	 http://bioin	fo.iconc	ologia.net/SNPstats	
and	MEDCALC	online	software	available	from	https://www.medca	
lc.org/calc/odds_ratio.	 The	 qRT-PCR	 amplification	 efficiency	 was	
assessed	using	LinRegPCR	software	 (version:	2017.1)	and	 for	each	
sample,	the	cycle	threshold	(Ct)	and	mean	PCR	efficiencies	were	de-
termined.	All	the	analyses	were	performed	using	SPSS	16.0	unless	
otherwise	specified.	The	two-tailed	t test was used to analyze the 
TA B L E  2   Primer sequences for CYP27B1 rs4646536 and CYP2R1	rs12794714	and	rs10766196	genotyping
SNP Primer Primer Sequence (5′-3′) Amplicon size Ta
CYP27B1 rs4646536 FI primer CTTCAGCCCCTAGCCTCATCTGGT 149	bp	(C	allele)
RI primer TCTAGGTTGCAAAGCACAAAATGGAGAAAG 212	bp	(T	allele) 58°C
FO primer GCAACTAGTGGATGGAAGCAGGGAGAT 307	bp	(Control)
RO primer TAGGAGAGTGTTTGAGAACAGGGTTGGG
CYP2R1	rs12794714 FI primer TTTCTCATGTAGACATGGGGAAGCGCA 152	bp	(G	allele)
RI primer ATCTATTCCCTGGCAGCCTCAGCC 205	bp	(A	allele) 63°C
FO primer CATAAGTCCAACCAGGAAGGCCCTG 307	bp	(Control)
RO primer CGATGTGGAAGCTTTGGAGAGCTGAAGA
CYP2R1	rs10766196 FI primer CTTGATTTTCCGACAAGCCGCGTTCG 127	bp	(A	allele)
RI primer TCTGCCTCGCAGCTCTGTGGAATCT 187	bp	(G	allele) 63.6°C
FO primer AGCAAACGCCTACACCAGTCGTTCGTC 264	bp	(Control)
RO primer TCCGAGGCGATCCAGTCCTGATTTTCC
Note: The nucleotide specificity is indicated in parentheses.
Abbreviations:	bp,	base	pair;	F,	forward;	I,	inner;	O,	outer;	R,	reverse;	SNP,	single-nucleotide	polymorphism;	Ta,	annealing	temperature.
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association	between	the	expression	levels	and	the	clinicopathologi-
cal features of the CRC patients. P > .05 was considered statistically 
significant.
3  | RESULTS
3.1 | CYP2R1, CYP27B1, and CYP27A1 expression 
levels in colorectal cancer tissues
We measured CYP27B1,	 CYP27A1,	 and	 CYP2R1	 expression	 levels	
using	qRT-PCR.	Overall,	the	results	indicated	that	2.3	and	2.7	upreg-
ulation of CYP2R1 and CYP27B1 genes in colorectal cancer tissues 
compared	to	the	adjacent	tissues,	respectively.	CYP2R1 and CYP27B1 
genes'	expression	was	significantly	upregulated	in	CRC	tissues	com-
pared	with	adjacent	tissues	(Figure	1A,B).	CYP27A1	gene	expression	
did	not	show	any	significant	expression	alteration	when	comparing	
the	CRC	tissues	with	adjacent	tissues	(Figure	1A).	The	correlations	
between	the	expression	of	CYP2R1,	CYP27B1,	and	CYP27A1 genes 
and clinicopathological features are shown in Table 3. None of the 
clinicopathological characteristics were significantly correlated with 
these genes.
3.2 | Genotyping
A	total	of	245	CRC	patients	(130	males	and	115	females)	with	an	av-
erage age of 54.87 ±	10.31	years	and	245	cancer-free	controls	(128	
males	and	117	females)	with	a	mean	age	of	53.11	± 11.22 years were 
analyzed	in	our	study.	All	controls	were	from	the	same	ethnic	back-
ground	(Iranian	population).	The	CRC	patients	and	normal	controls	
were	well	 matched	 concerning	 their	 ages	 and	 sex	 ratio	 (P >	 .05).	
Table 4 describes the demographic variables and clinical character-
istics of the studied subjects. Our study investigated the association 
of CYP27B1 rs4646536 and CYP2R1	 rs12794714	 and	 rs10766196	
polymorphisms with CRC risk in recessive and dominant inheritance 
models. Genotype and allelic frequencies of CYP27B1 rs4646536 
and CYP2R1	rs12794714	and	rs10766196	polymorphisms	are	shown	
in Table 5. The genotype distributions of CYP27B1 rs4646536 and 
CYP2R1	rs12794714	and	rs10766196	polymorphisms	were	in	Hardy-
Weinberg	equilibrium	(P >	.05).	Regarding	the	CYP2R1	rs12794714,	
the	 AG	 genotype	 increased	 the	 risk	 of	 CRC	 (P = .03; odds ratio 
[OR] =	 1.55;	 95%	 confidence	 interval	 [CI]:	 1.03-2.34).	 In	 addition,	
the genotype frequencies showed significant differences under the 
dominant	model	(P = .03; OR =	1.50;	95%	CI,	1.02-2.21).	There	was	
no significant association between the CYP27B1 rs4646536 and 
CYP2R1	 rs10766196	alleles	 and	genotypes	 and	CRC	 risk	 in	 any	of	
the	inheritance	models	(Table	5).	Figure	2	represents	2%	agarose	gel	
electrophoresis	for	identification	of	CYP2R1	rs12794714	genotypes.
4  | DISCUSSION
Vitamin	D	deficiency	is	inversely	associated	with	the	incidence	and	
mortality of colorectal cancer.21	 Under	 physiological	 conditions,	
CYP27B1 and CYP2R1	genes	control	the	vitamin	D	synthesis,	and	vi-
tamin	D	also	controls	the	expression	level	of	these	genes.9,22 CYP2R1 
and CYP27B1	are	dysregulated	in	different	types	of	cancer,	but	the	
mechanism behind the dysregulation is not clearly defined.23-26 In the 
current	study,	we	first	measured	the	expression	levels	of	CYP27A1,	
CYP27B1,	 and	CYP2R1 in CRC samples. CYP27B1 and CYP2R1	 ex-
pression ratios were significantly different when comparing CRC 
F I G U R E  1  The	relative	expression	levels	(ΔCt)	of	CYP2R1	(A),	CYP27B1	(B),	and	CYP27A1	(C)	genes	in	CRC	samples	compared	to	
controls.	A	and	B	suggest	that	CYP2R1 and CYP27B1 genes were upregulated in CRC samples compared with controls. The mean ± standard 
deviation	(SD)	for	CYP2R1 CRC tissues and adjacent tissues were 8.31 ± 6.53 and 12.21 ±	5.85,	respectively.	The	mean	±	SD	for	CYP27B1 
CRC tissues and adjacent tissues were 7.78 ± 3.76 and 12.21 ±	5.59,	respectively.	As	shown	in	C	the	expression	of	CYP27A1 gene was not 
different between the studied groups. The mean ±	SD	for	CYP27A1 CRC tissues and adjacent tissues were 4.01 ± 14.73 and 5.07 ±	13.95,	
respectively.	The	relative	expression	levels	comparison	between	CRC	samples	and	controls	was	applied	by	paired	t	test.	The	asterisk	sign	(*)	
represents P < .05
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tissues	 with	 the	 adjacent	 tissues.	 In	 comparison	 with	 our	 results,	
dysregulated	expression	of	CYP2R1 and CYP27B1 genes had been 
shown	in	different	types	of	cancer,	including	oral	squamous	cell	car-
cinomas and colorectal cancer.6,27 We did not find any correlation 
between	mentioned	genes	expression	levels	and	clinicopathological	
characteristics	 in	 the	 studied	 patients.	 A	 number	 of	 inconsistent	
studies	have	shown	that	SNPs	in	both	CYP27B1 and CYP2R1 genes 
may or may not be related to the CRC risk and circulating concen-
trations of vitamin D metabolites.15-17,28-30	Furthermore,	at	the	pro-
tein	level,	SNPs	in	the	CYP27B1 gene body could alter the CYP27B1 
enzymatic activity.31 To clarify whether variants in the vitamin D 
metabolism	pathway	were	associated	with	CRC	risk,	we	conducted	
a	 case-control	 study	 to	 investigate	 the	 association	between	 three	
SNPs	 in	CYP27B1 and CYP2R1 genes and CRC risk. Regarding the 
CYP2R1	rs12794714	polymorphism,	AG	genotype	increased	the	risk	
of	CRC	in	the	patients	(P = .03; odds ratio [OR] =	1.55;	95%	confi-
dence	interval	[CI],	1.03-2.34).	In	addition,	we	observed	that	CYP2R1 
rs12794714	was	associated	with	the	risk	of	CRC	under	the	dominant	
model	(P =	.039	OR	=	1.50;	95%	CI,	1.02-2.21).	In	a	previous	study,	
Nam et al18 showed that the CYP2R1	rs12794714	GG	genotype	and	
CYP2R1	rs10766196	AA	genotype	were	associated	with	the	risk	of	
developing type 1 diabetes in Korean children. Dorjgochoo et al32 
also reported no association between CYP2R1	rs12794714	polymor-
phism	and	 the	 risk	of	breast	 cancer	 in	Chinese	women.	 In	African	
Americans,	CYP2R1	rs12794714	was	associated	with	a	decreased	risk	
of CRC.16	The	AAGA	haplotype	of	CYP2R1	rs7936142-rs12794714-
rs2060793-rs16930609	 was	 associated	 with	 a	 lower	 25(OH)D	
concentration in the healthy Chinese population.33	Under	 the	 ad-
ditive	and	recessive	models,	the	exonic	variant	CYP2R1	rs12794714	
was	significantly	associated	with	plasma	25(OH)D	concentration	in	
northeastern	Han	Chinese	children	and	people	of	Arab	origin.31,34 
According	 to	 the	 HaploReg,35	 RegulomeDB,36 and PROMO37 on-
line	databases,	it	is	suggested	that	the	CYP2R1	rs12794714	variant	
may	 influence	 the	binding	affinity	of	 several	 transcription	 factors,	
including	ELF1,	HNF4,	SMARCA4,	CDX2,	and	PEA3	in	different	cell	
types	such	as	the	Caco-2	colon	cancer	cell	line.	In	addition,	accord-
ing	 to	 rSNPBase,38 CYP2R1	 rs12794714	 may	 affect	 the	 proximal	
and	distal	regulation	and	RNA	binding	protein-mediated	regulation.	
These	 transcription	 factors	 have	 important	 functions.	HNF4α is a 
TA B L E  3   The correlation of CYP2R1,	CYP27B1, and CYP27A1	expression	levels	(ΔCt)	and	clinicopathological	features	of	the	CRC	patients
Factors
No. of patients 
(%)
CYP2R1 CYP27B1 CYP27B1
Mean ± SD P value Mean ± SD P value Mean ± SD P value
Age	(y)
>60 40	(53) 8.82 ± 3.6 .35 8.03 ± 4.12 .63 5.41 ± 5.15 .79
≤60 35	(47) 7.97	± 4.01 7.87 ± 3.20 4.37 ± 4.24
Gender
Male 44	(59) 10.11 ± 3.54 .22 7.92	± 3.81 .37 6.73 ± 6.22 .29
Female 31	(41) 8.93	± 3.17 6.76 ± 3.43 4.06 ± 4.74
Stage
I & II 55	(73) 8.72 ± 8.45 .65 8.53 ± 4.33 .42 5.44 ±	9.38 .12
III	&	IV 20	(27) 9.77	± 8.33 7.73 ± 5.84 2.75 ± 7.88
Location
Colon 50	(67) 7.17 ± 6.38 .48 8.64 ± 3.86 .12 4.93	± 2.26 .19
Rectum 25	(33) 9.74	± 5.83 6.40 ± 4.82 5.84 ± 3.08
TA B L E  4   Demographic data and clinical characteristics of the 
study participants for association study
Characteristics
CRC (n = 245) 
patients
non-cancer 
controls (n = 245)
Median	age,	y 54.87 ± 10.31 53.11 ± 11.22
Gender
Male 130 128
Female 115 117
Primary tumor location
Colon 64%
Rectum 25%
Cecum 11%
Differentiation
Well-differentiated 41%
Moderately 
differentiated
22%
Poorly differentiated 8%
Not determined 29%
Cigarette smoking
No 74%
Yes 26%
Clinical	stages,	TNM
I 16%
II 48%
III 30%
IV 6%
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highly conserved transcription factor that plays a role as a tumor 
suppressor gene or an oncogene in colon cancer.39	CDX2	has	a	role	
in the progression of colorectal cancer and nominated as an inde-
pendent	 prognostic	 factor	 in	CRC.	Moreover,	 it	 serves	 a	 clinically	
useful marker for epithelial neoplasms of the gastrointestinal tract. 
Previous	 researches	 showed	 that	CDX2	might	 suppress	 colorectal	
tumorigenesis.	 Furthermore,	CRC	with	 advanced	 tumor	 stage	 and	
high	tumor	grade	lost	the	CDX2	expression.40,41 Pea3 is a prognostic 
marker	 in	CRC,	and	 the	expression	of	Pea3	promotes	 the	 invasive	
and metastatic potential of colorectal carcinoma.42	 Based	 on	 the	
results	of	our	 study,	 the	distributions	of	CYP27B1 rs4646536 and 
CYP2R1	rs10766196	were	not	associated	with	the	risk	of	CRC	in	any	
inheritance	model	 (P >	 .05).	 Furthermore,	 these	 SNPs	 showed	no	
significant differences in the allele and genotype frequencies when 
comparing	CRC	patients	with	healthy	individuals	(P >	.05).	In	agree-
ment	with	the	results	of	our	study,	previous	researches	showed	that	
there is no association between cases and controls in different types 
of cancer.43,44	Conversely,	in	contrast	to	our	study,	in	Chinese	popu-
lation,	CYP27B1 rs4646536 CC genotype reduced the risk of colorec-
tal cancer compared with the TT genotype.15	Penna-Martinez	et	al45 
revealed	 that	 the	 rs10877012A/rs4646536T	haplotype	within	 the	
CYP27B1 gene might be protective against papillary thyroid car-
cinoma. Dong et al17 suggested a lower risk of distal colon cancer 
among common allele homozygotes for CYP27B1 rs4646536 T>C 
in the individuals with at least one copy of the CYP24A1	rs2762942	
C>T rare allele.
In	conclusion,	we	showed	that	CYP2R1 and CYP27B1 genes were 
upregulated in CRC tissues compared to the adjacent control tissues. 
Besides,	CYP2R1	rs12794714	variant	was	associated	with	the	risk	of	
CRC in the studied samples. One of the limitations of this study was 
that	the	association	and	expression	studies	were	performed	on	dif-
ferent	samples,	and	we	cannot	correlate	the	tissue	expression	with	
Genotype/Allele
Case
N (%)
Control
N (%) OR (95% CI) P value
CYP27B1
rs4646536
C>T
T/T 117	(48) 111	(45) 1	(reference)
C/T 96	(39) 94	(38) 1.03	(0.70-1.52) .87
C/C 32	(13) 40	(16) 1.32	(0.77-2.24) .31
T/T vs C/T+C/C 1.10	(0.77-1.57) .59
T/T+C/T vs C/C 1.30	(0.79-2.15) .31
T 316	(64) 330	(67) 0.88	(0.68-1.15) .35
C 174	(36) 160	(33) 1.14	(0.87-1.48) .35
CYP2R
rs12794714
G>A
G/G 64	(26.1) 85	(34.7) 1	(reference)
A/G 131	(53.5) 112	(45.7) 1.55	(1.03-2.34) .03
A/A 50	(20.4) 48	(19.6) 1.38	(0.83-2.31) .21
G/G	vs	A/G-A/A 1.50	(1.02-2.21) .039
G/G-A/G	vs	A/A 1.05	(0.68-1.64) .82
G 259	(53) 282	(58) 0.83	(0.64-1.06) .14
A 231	(47) 208	(42) 1.21	(0.94-1.56) .14
CYP2R
rs10766196
A>G
A/A 97	(39.6) 90	(36.7) 1	(reference)
A/G 127	(51.8) 127	(51.8) 0.93	(0.64-1.35) .39
G/G 21	(8.6) 28	(11.4) 0.70	(0.37-1.31 .26
A/A	vs	A/G-G/G 0.89	(0.62-1.28) .52
A/A-A/G	vs	G/G 0.73	(0.40-1.32) .29
A 321	(66) 307	(63) 1.13	(0.87-1.47) .35
G 169	(34) 183	(37) 0.88	(0.68-1.15) .35
Note: P < .05 was considered statistically significant.
Abbreviations:	CI,	confidence	interval;	OR,	odds	ratio.
TA B L E  5  Allele	and	genotype	
frequencies of CYP27B1 rs4646536 
CYP2R1	rs12794714	and	rs10766196	in	
CRC	patients	and	controls.	The	SNPStats	
and	MEDCALC	online	software	were	
used for descriptive analysis and analysis 
of	single	SNPs:	dominant	and	recessive	
inheritance models
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the	different	 genotypes.	 Furthermore,	 investigations	with	 a	 larger	
sample	 size	are	 recommended	 to	estimate	 the	 role	of	 rs12794714	
variant	in	the	expression	of	CYP2R1.
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